HomeCoronavirus
Coronavirus
COVID-19 generally a mild disease in children — Analysis of 582 European patients
Children with COVID-19 generally experience a mild disease and fatalities are very rare, according to a study of 582 patients from across Europe. The...
Far-UVC light safely kills airborne coronaviruses — Columbia University
More than 99.9% of seasonal coronaviruses present in airborne droplets were killed when exposed to a particular wavelength of ultraviolet light that is safe...
Leeds research review confirms WHO's 'classic' symptoms of COVID-19
Persistent cough and fever have been confirmed as the most prevalent symptoms associated with COVID-19, according to a major review of the scientific literature....
Black men in England and Wales 3x more likely to die from COVID-19 — National Office of Statistics
Black men in England and Wales are three times more likely to die from COVID-19 than white men, The Guardian reports that the Office...
How COVID-19 affects paediatric patients — China study in PLOS Medicine
New insights into the clinical and epidemiological characteristics of paediatric patients with coronavirus disease 2019 (COVID-19) could facilitate early identification and intervention in suspected...
SA doctor experiences rare spinal paralysis from COVID-19
Initially, COVID-19 had not made him that ill. News24 reports that on one day, he struggled with a nasal drip, a sore throat on...
FDA revokes emergency use authorisation for chloroquine phosphate and hydroxychloroquine sulfate
The US Food and Drug Administration (FDA) has revoked the emergency use authorisation (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to...
Comorbidities increase death risk twelvefold — US Centres for Disease Control
People with chronic health conditions such as heart disease and diabetes were hospitalised six times more often than otherwise healthy individuals infected with the...
Up to 45% of covid infections may be asymptomatic — Scripps analysis
An extraordinary percentage of people infected by the virus behind the ongoing deadly COVID-19 pandemic never show symptoms of the disease, according to the...
Age-dependent effects in COVID-19 transmission and control — London School of Hygiene & Tropical Medicine
People under 20 years of age are approximately half as susceptible to COVID-19 as are people 20 years of age and older, according to...
COVID-19 may trigger new diabetes — NEJM expert letter
Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes. A...
Steroid treatment for sickest COVID-19 patients a 'major breakthrough'
Dexamethasone, a cheap and widely-used steroid, has become the first drug shown to save COVID-19 lives, in what University of Oxford scientists said is...
One in five UK hospital patients caught COVID-19 while on wards — SAGE paper
Papers by UK government scientists have revealed that one in five hospital patients with coronavirus caught it while on wards, reports The Daily Telegraph....
Airborne transmission is dominant route for spread of COVID-19 — US analysis
A study by a team of researchers led by a Texas A&M University professor has found that not wearing a face mask dramatically increases...
Non-allergic asthma increases severe COVID-19 risk — Harvard study
Adults with asthma who became infected with the coronavirus that causes COVID-19 were at higher risk of developing severe illness compared with adults who...
Baldness 'a perfect predictor' of higher risk of severe COVID-19 – Research letter
Bald men may be at higher risk of suffering from severe COVID-19 symptoms, The Daily Telegraph reports emerging evidence suggests. The link is so...
Experimental drug to prevent COVID-19 blood clots — Imperial College trial
The British Heart Foundation is funding a trial for an experimental drug that could prevent the life-threatening blood clots that are seen in the...
ICL researchers begin human trials of a new coronavirus vaccine
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study...
COVID-19 antibodies may remain stable for two months after diagnosis
Initial results from an antibody testing study have revealed that COVID-19 antibodies remain stable in the blood of the majority of infected individuals almost...
Super-potent human antibodies protect against COVID-19 in animal tests — Scripps
A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus...
Combo drug treatments for COVID-19 show promise in cell culture tests — Norway/Estonia study
Six months into the COVID-19 pandemic, more than 7.4m people have been infected, and more than 410,000 have died. As yet, there is no...
Novel alternative to PCR test diagnoses COVID-19 virus in 30 mins
A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in...
Self-swabbing tests for COVID-19 accurate and safe — Small Stanford study
Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected...
Mapping pandemic disease burden across US — Princeton
Per capita COVID-19 disease burden and healthcare system demand may be highest in rural areas in the US, according to a modelling study. These...
Potential approach to treating severe COVID-19 — US National Institutes of Health clinical study
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients...
Remdesivir slows COVID-19 disease progression in macaques — US National Institutes of Health
Early treatment with the antiviral drug remdesivir is shown to reduce viral load and prevent lung disease in macaques infected with SARS-CoV-2, reports a...
Most-used COVID-19 test may miss 1 in 5 infections
The majority test for the novel coronavirus — a back of nose or throat swab using the RT-PCR laboratory procedure for genetic analysis —...
Hydroxychloroquine no better than placebo to prevent COVID-19 — First randomised clinical trial
University of Minnesota Medical School researchers have published the results from the first randomised clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19....
No clinical benefit from hydroxychloroquine in hospitalised COVID-19 patients — RECOVERY trial
A new statement has been released from the chief investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine. Professor Peter Horby...
Australian COVID-19 Clinical Evidence Taskforce recommends remdesivir for treatment
The antiviral drug remdesivir has been recommended for the treatment of COVID-19 patients in Australia, by the national taskforce bringing together the country’s peak...
Underlying illness risk factors for severe COVID-19 or death — Large UK cohort study
Age, male sex, obesity, and underlying illness have emerged as risk factors for severe COVID-19 or death in the UK, according to the largest...
Kawasaki-like syndrome more common among children of African ancestry — Small French study
An inflammatory syndrome in children and adolescents, believed to be linked to COVID-19, seems to be more common among children of African ancestry, finds...
Coronavirus linked to stroke in otherwise healthy young people — Small US observational study
Young patients with no risk factors for stroke may have an increased risk if they have contracted COVID-19, whether or not they are showing...
COVID-19 outbreak lasts 2.4 days longer for each day's delay in social distancing
Epidemiological researchers at The University of Texas at Austin, Dalian Minzu University, University of Cambridge, University of Hong Kong and Yale School of Public...
Early evidence of pronounced brain involvement in fatal COVID-19 outcomes — 6 autopsies
The first cases of COVID-19 in Germany were confirmed in the greater Munich area and isolated in our hospital. Subsequently, more than 690 patients...
Different blood biomarkers could predict COVID-19 disease progression
Researchers from Charité-Universitätsmedizin Berlin and the Francis Crick Institute have identified 27 proteins which are present at different levels in the blood of COVID-19...
Evidence supports physical distancing, masks, and eye protection — WHO commissioned meta-analysis
A comprehensive review of existing evidence supports physical distancing of two metres or more to prevent person-to-person transmission of COVID-19, says an international team...
How lockdown altered SARS-Ccov-2 transmission in Europe — 11-country modelling study
Large-scale lockdowns and other non-pharmaceutical interventions in Europe have been successful in reducing the transmission levels of SARS-CoV-2 enough to control the epidemic growth,...
Assessing effect of anti-contagion policies on COVID-19 pandemic — 6-nation analysis
The effects of large-scale anti-contagion policies, such as lockdowns and travel restrictions, that have been implemented by governments to slow down the rate of...
Arthritis drug may be efficacious with COVID-19 — Small French retrospective cohort study
French doctors administered anakinra, an anti-inflammatory drug normally used to treat rheumatoid arthritis, to 52 COVID-19 patients at the Saint-Joseph Public Hospital in Paris...